Caribou Biosciences (CRBU) Receivables - Other (2020 - 2026)
Caribou Biosciences (CRBU) posted quarterly Receivables - Other of $1.4 million for Q1 2026, down 21.64% year-over-year from $1.8 million in Q1 2025, and up 1801.32% quarter-over-quarter from $76000.0 in Q4 2025.
Caribou Biosciences (CRBU) Receivables - Other (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has reported Receivables - Other for 7 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other fell 21.64% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 21.64% YoY), while the FY2025 annual figure was $1.9 million, up 4.16% from the prior year.
- Receivables - Other improved to $1.4 million in Q1 2026 per CRBU's latest filing, from $76000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $4.2 million in Q1 2022 and bottomed at -$485000.0 in Q4 2022.
- Historically, Receivables - Other has averaged $1.6 million across 5 years, with a median of $1.7 million in 2024.
- Annual changes were most pronounced in 2022 — Receivables - Other tumbled 481.89% — and 2024, when it jumped 345.76%.
- Caribou Biosciences' Receivables - Other stood at -$485000.0 in 2022, then soared by 87.84% to -$59000.0 in 2023, then soared by 345.76% to $145000.0 in 2024, then tumbled by 47.59% to $76000.0 in 2025, then surged by 1801.32% to $1.4 million in 2026.
- Business Quant data shows CRBU's Receivables - Other at $1.4 million in Q1 2026, $76000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Caribou Biosciences | 163.09 Mn | 50.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 76,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Sep 30, 2025 | 1.83 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 145,000.00 |
| Dec 31, 2024 | 145,000.00 |
| Sep 30, 2024 | 1.68 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |